News

The small business innovation research (SBIR) grant supports research to optimize a human protein to enhance its ability to inhibit formation of new blood vessels, which may provide

As part of the ongoing review of COX-2 inhibitors, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) held hearings with Pfizer for Onsenal, Dynastat

Worldwide sales of Celebrex topped $3.3 billion and Bextra sales totaled nearly $1.3 billion in 2004. Pfizer’s Lipitor also delivered strong double-digit revenue growth, becoming the world’s first

Novartis’ net sales rose 14% to $28.2 billion, with strong results being recorded in both pharmaceuticals and consumer health, where the company’s OTC and medical nutrition operations offset

The vaccine candidate will be manufactured using GenVec’s proprietary adenovector technology and 293-ORF6 cell line based manufacturing process. The vaccine is based on two antigens and is designed

This open-label, non-randomized study will seek to enroll patients who have received one prior chemotherapy regimen and may or may not have received an EGFR Kinase inhibitor to

The phase II proof of principle study is to evaluate Phytompharm’s PYM50028 (Cogane), an orally active, synthetic, neuroprotective and neuroregenerative product under development as a treatment for Alzheimer’s

The research and license collaboration is focused on Rigel’s preclinical small molecule compounds, which inhibit IgE receptor signaling in respiratory tract mast cells by blocking the signaling enzyme

The final agreements, signed on January 20, 2005, specify the purchase of 100% ownership of Biogenesis Ltd and Biogenesis Inc by MorphoSys for GBP5.25 million, less net debt